West Pharmaceutical Services, Inc. (WST)
USD 230.77
(2.09%)
USD 230.77
(2.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 847.8 Million USD | 2.47% |
| 2022 | 887.9 Million USD | -2.71% |
| 2021 | 895.2 Million USD | 69.84% |
| 2020 | 531.7 Million USD | 29.33% |
| 2019 | 399.4 Million USD | 61.9% |
| 2018 | 355.3 Million USD | 7.91% |
| 2017 | 335.9 Million USD | 16.31% |
| 2016 | 319.6 Million USD | 53.03% |
| 2015 | 220 Million USD | -29.34% |
| 2014 | 273.3 Million USD | 12.07% |
| 2013 | 249 Million USD | 14.53% |
| 2012 | 200 Million USD | 12.9% |
| 2011 | 183.4 Million USD | 5.63% |
| 2010 | 161.3 Million USD | 13.24% |
| 2009 | 166.4 Million USD | -6.17% |
| 2008 | 186.1 Million USD | -46.23% |
| 2007 | 157.5 Million USD | 26.5% |
| 2006 | 149.9 Million USD | 21.22% |
| 2005 | 122.9 Million USD | 59.84% |
| 2004 | 94.5 Million USD | 0.12% |
| 2003 | 84.8 Million USD | 8.86% |
| 2002 | 82.8 Million USD | 0.39% |
| 2001 | 74.7 Million USD | -15.65% |
| 2000 | 75.9 Million USD | -8.73% |
| 1999 | 102.1 Million USD | -20.32% |
| 1998 | 97 Million USD | 37.2% |
| 1997 | 93.8 Million USD | -10.57% |
| 1996 | 84 Million USD | 36.56% |
| 1995 | 77.9 Million USD | 5.74% |
| 1994 | 70.2 Million USD | 14.06% |
| 1993 | 63.1 Million USD | -1.11% |
| 1992 | 63.3 Million USD | 186.43% |
| 1991 | 23.2 Million USD | -47.15% |
| 1990 | 43.9 Million USD | -22.16% |
| 1989 | 56.4 Million USD | 14.4% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 169.7 Million USD | 4.47% |
| 2024 Q3 | 205.4 Million USD | 21.97% |
| 2024 Q1 | 158.4 Million USD | -22.83% |
| 2023 Q2 | 220.6 Million USD | 18.03% |
| 2023 Q1 | 186.9 Million USD | 44.1% |
| 2023 FY | - USD | 2.47% |
| 2023 Q3 | 218.6 Million USD | -0.91% |
| 2023 Q4 | 214 Million USD | -2.1% |
| 2022 Q2 | 257.1 Million USD | 18.75% |
| 2022 FY | - USD | -2.71% |
| 2022 Q1 | 216.5 Million USD | 17.54% |
| 2022 Q4 | 129.7 Million USD | -23.21% |
| 2022 Q3 | 168.9 Million USD | -34.31% |
| 2021 Q4 | 184.2 Million USD | -13.93% |
| 2021 FY | - USD | 69.84% |
| 2021 Q1 | 205.8 Million USD | 41.44% |
| 2021 Q2 | 241.5 Million USD | 17.35% |
| 2021 Q3 | 214 Million USD | -11.39% |
| 2020 FY | - USD | 29.33% |
| 2020 Q2 | 130 Million USD | 14.34% |
| 2020 Q1 | 113.7 Million USD | 8.8% |
| 2020 Q3 | 128 Million USD | -1.54% |
| 2020 Q4 | 145.5 Million USD | 13.67% |
| 2019 Q2 | 81 Million USD | 13.6% |
| 2019 Q1 | 71.3 Million USD | 5.79% |
| 2019 Q3 | 66 Million USD | -18.52% |
| 2019 Q4 | 104.5 Million USD | 58.33% |
| 2019 FY | - USD | 61.9% |
| 2018 Q4 | 67.4 Million USD | 7.67% |
| 2018 Q1 | 55 Million USD | -9.84% |
| 2018 Q2 | 62 Million USD | 12.73% |
| 2018 Q3 | 62.6 Million USD | 0.97% |
| 2018 FY | - USD | 7.91% |
| 2017 Q2 | 42.7 Million USD | -30.34% |
| 2017 Q1 | 61.3 Million USD | 12.89% |
| 2017 Q3 | 63.9 Million USD | 49.65% |
| 2017 Q4 | 61 Million USD | -4.54% |
| 2017 FY | - USD | 16.31% |
| 2016 Q2 | 61.2 Million USD | 104.0% |
| 2016 FY | - USD | 53.03% |
| 2016 Q3 | 51.3 Million USD | -16.18% |
| 2016 Q1 | 30 Million USD | -33.63% |
| 2016 Q4 | 54.3 Million USD | 5.85% |
| 2015 Q1 | 47.8 Million USD | 7.17% |
| 2015 FY | - USD | -29.34% |
| 2015 Q2 | 39.1 Million USD | -18.2% |
| 2015 Q3 | -3.5 Million USD | -108.95% |
| 2015 Q4 | 45.2 Million USD | 1391.43% |
| 2014 Q3 | 44 Million USD | -18.67% |
| 2014 FY | - USD | 12.07% |
| 2014 Q1 | 39.3 Million USD | 6.5% |
| 2014 Q2 | 54.1 Million USD | 37.66% |
| 2014 Q4 | 44.6 Million USD | 1.36% |
| 2013 Q3 | 39.7 Million USD | -6.59% |
| 2013 FY | - USD | 14.53% |
| 2013 Q4 | 36.9 Million USD | -7.05% |
| 2013 Q2 | 42.5 Million USD | -1.85% |
| 2013 Q1 | 43.3 Million USD | 35.31% |
| 2012 Q1 | 42.9 Million USD | -15.22% |
| 2012 FY | - USD | 12.9% |
| 2012 Q2 | 55 Million USD | 28.21% |
| 2012 Q4 | 32 Million USD | 14.7% |
| 2012 Q3 | 27.9 Million USD | -49.27% |
| 2011 FY | - USD | 5.63% |
| 2011 Q1 | 32.6 Million USD | -19.31% |
| 2011 Q2 | 29 Million USD | -11.04% |
| 2011 Q3 | 27.4 Million USD | -5.52% |
| 2011 Q4 | 50.6 Million USD | 84.67% |
| 2010 Q1 | 29.5 Million USD | -42.38% |
| 2010 FY | - USD | 13.24% |
| 2010 Q4 | 40.4 Million USD | 70.46% |
| 2010 Q3 | 23.7 Million USD | -23.3% |
| 2010 Q2 | 30.9 Million USD | 4.75% |
| 2009 Q3 | 22 Million USD | -24.14% |
| 2009 Q4 | 51.2 Million USD | 132.73% |
| 2009 FY | - USD | -6.17% |
| 2009 Q2 | 29 Million USD | -22.46% |
| 2009 Q1 | 37.4 Million USD | -22.57% |
| 2008 Q3 | 37.4 Million USD | -22.41% |
| 2008 Q4 | 48.3 Million USD | 29.14% |
| 2008 Q1 | 53.7 Million USD | -22.06% |
| 2008 FY | - USD | -46.23% |
| 2008 Q2 | 48.2 Million USD | -10.24% |
| 2007 Q2 | 49 Million USD | -8.92% |
| 2007 Q4 | 68.9 Million USD | 89.29% |
| 2007 Q1 | 53.8 Million USD | 51.98% |
| 2007 FY | - USD | 26.5% |
| 2007 Q3 | 36.4 Million USD | -25.71% |
| 2006 Q4 | 35.4 Million USD | 1.43% |
| 2006 Q1 | 47.6 Million USD | -5.74% |
| 2006 FY | - USD | 21.22% |
| 2006 Q2 | 46.6 Million USD | -2.1% |
| 2006 Q3 | 34.9 Million USD | -25.11% |
| 2005 Q3 | 26 Million USD | -7.47% |
| 2005 FY | - USD | 59.84% |
| 2005 Q4 | 50.5 Million USD | 94.23% |
| 2005 Q2 | 28.1 Million USD | -9.94% |
| 2005 Q1 | 31.2 Million USD | 6.48% |
| 2004 Q3 | 15 Million USD | -27.54% |
| 2004 FY | - USD | 0.12% |
| 2004 Q2 | 20.7 Million USD | 4.02% |
| 2004 Q4 | 29.3 Million USD | 95.33% |
| 2004 Q1 | 19.9 Million USD | -22.87% |
| 2003 Q3 | 14.7 Million USD | -31.6% |
| 2003 FY | - USD | 8.86% |
| 2003 Q2 | 19.3 Million USD | 14.93% |
| 2003 Q1 | 14.6 Million USD | 23.31% |
| 2003 Q4 | 25.8 Million USD | 63.29% |
| 2002 Q3 | 15 Million USD | 44.57% |
| 2002 FY | - USD | 0.39% |
| 2002 Q1 | 20.6 Million USD | 26.17% |
| 2002 Q2 | 18.1 Million USD | -6.91% |
| 2002 Q4 | 15.7 Million USD | -35.57% |
| 2001 Q3 | 18.3 Million USD | -5.33% |
| 2001 Q4 | 14.9 Million USD | -6.88% |
| 2001 Q1 | 10.8 Million USD | -57.65% |
| 2001 Q2 | 16.9 Million USD | 56.48% |
| 2001 FY | - USD | -15.65% |
| 2000 Q3 | 7.9 Million USD | -27.52% |
| 2000 Q1 | 10.7 Million USD | -22.46% |
| 2000 FY | - USD | -8.73% |
| 2000 Q2 | 10.9 Million USD | 1.87% |
| 2000 Q4 | 5.6 Million USD | 222.78% |
| 1999 Q4 | 13.8 Million USD | -6.76% |
| 1999 Q1 | 17.3 Million USD | -76.49% |
| 1999 Q2 | 20.1 Million USD | 17.92% |
| 1999 Q3 | 14.8 Million USD | -27.45% |
| 1999 FY | - USD | -20.32% |
| 1998 Q4 | 45.9 Million USD | 271.72% |
| 1998 Q3 | 16.1 Million USD | 31.13% |
| 1998 FY | - USD | 37.2% |
| 1998 Q1 | -14.3 Million USD | -181.71% |
| 1998 Q2 | 15.1 Million USD | 205.59% |
| 1997 Q3 | 11.7 Million USD | -29.94% |
| 1997 FY | - USD | -10.57% |
| 1997 Q1 | 14.4 Million USD | -5.88% |
| 1997 Q2 | 16.7 Million USD | 15.97% |
| 1997 Q4 | 17.1 Million USD | 49.57% |
| 1996 Q1 | 12.2 Million USD | 209.26% |
| 1996 Q3 | 10.7 Million USD | -17.69% |
| 1996 Q4 | 15.3 Million USD | 42.99% |
| 1996 FY | - USD | 36.56% |
| 1996 Q2 | 13 Million USD | -61.08% |
| 1995 Q3 | 7.5 Million USD | -36.97% |
| 1995 Q1 | 15.3 Million USD | 29.75% |
| 1995 Q2 | 11.9 Million USD | -24.2% |
| 1995 Q4 | 10.8 Million USD | 44.0% |
| 1995 FY | - USD | 5.74% |
| 1994 Q3 | 9.6 Million USD | -25.0% |
| 1994 Q4 | 11 Million USD | 26.04% |
| 1994 FY | - USD | 14.06% |
| 1994 Q1 | 13.4 Million USD | 14.75% |
| 1994 Q2 | 12.8 Million USD | -8.57% |
| 1993 FY | - USD | -1.11% |
| 1993 Q1 | 8 Million USD | -2.44% |
| 1993 Q2 | 11 Million USD | 37.5% |
| 1993 Q3 | 9 Million USD | -14.55% |
| 1993 Q4 | 11.8 Million USD | 29.79% |
| 1992 FY | - USD | 186.43% |
| 1992 Q4 | 8.2 Million USD | 7.89% |
| 1992 Q3 | 7.6 Million USD | -33.91% |
| 1992 Q2 | 11.5 Million USD | -2.54% |
| 1992 Q1 | 11.4 Million USD | 145.21% |
| 1991 Q3 | 7.5 Million USD | 1.35% |
| 1991 Q2 | 7.4 Million USD | -16.85% |
| 1991 Q1 | 8.9 Million USD | 23.61% |
| 1991 FY | - USD | -54.15% |
| 1991 Q4 | -26.1 Million USD | -448.0% |
| 1990 Q4 | 500 Thousand USD | 24.14% |
| 1990 Q1 | 8.5 Million USD | 104.41% |
| 1990 FY | - USD | -7.84% |
| 1990 Q3 | 5.7 Million USD | 28.89% |
| 1990 Q2 | 4.5 Million USD | -47.06% |
| 1989 FY | - USD | 11.99% |
| 1989 Q2 | 79.5 Million USD | -0.75% |
| 1989 Q1 | 80.1 Million USD | 143.91% |
| 1989 Q3 | 69.4 Million USD | -12.7% |
| 1989 Q4 | -192.9 Million USD | -377.95% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alcon Inc. | 2.39 Billion USD | 64.572% |
| AptarGroup, Inc. | 663.83 Million USD | -27.712% |
| Baxter International Inc. | 2.77 Billion USD | 69.46% |
| Becton, Dickinson and Company | 2.42 Billion USD | 65.039% |
| Bausch + Lomb Corporation | 586 Million USD | -44.676% |
| Haemonetics Corporation | 262.09 Million USD | -223.467% |
| Envista Holdings Corp | 171.1 Million USD | -395.5% |
| ResMed Inc. | 1.6 Billion USD | 47.023% |
| Teleflex Incorporated | 792.26 Million USD | -7.01% |
| Warby Parker Inc. | -30.21 Million USD | 2906.17% |